Preclinical Development of Atr Inhibitor VE-822, Delivered Systemically in Nanoparticles, for Medulloblastoma Therapy |
University of North Carolina |
Cure4Cam Childhood Cancer Foundation, I Care I Cure |
Pharmacogenomics and Drug Screening Lead to a Novel Targeted Therapy with Potent and Specific Activity Against Mouse Models of MYCN-amplified Neuroblastoma |
Virginia Commonwealth University |
Cure4Cam Childhood Cancer Foundation, I Care I Cure |
Immunotherapy of Neuroblastoma with CAR.GD2 NKT Cells |
Baylor College of Medicine |
Cure4Cam Childhood Cancer Foundation |
HA-1 TCR T-cell Immunotherapy for Acute Leukemia |
Fred Hutchinson Cancer Research Center |
Cure4Cam Childhood Cancer Foundation, Marshall County Childhood Cancer Awareness Corporation |
Two-pronged Cell Therapy: Engineering T Cells to Redirect Bystander T- and NK-Cells to Pediatric Cancer |
Baylor College of Medicine |
Cure4Cam Childhood Cancer Foundation |
Development of AAV Vectors for Efficient Targeting and Elimination of Osteosarcoma Tumor-Initiating Cells |
University of Florida |
Cure4Cam Childhood Cancer Foundation |
Targeting the Six1/Eya Transcriptional Complex to Inhibit Pediatric Sarcomas |
University of Colorado Denver |
Cure4Cam Childhood Cancer Foundation |
B-lapachone as a Novel Targeted Therapy for ATRTs and other Pediatric Cancers
|
University of Texas Southwestern Medical Center |
Cure4Cam Childhood Cancer Foundation |
Development of a Novel Mer Tyrosine Kinase Inhibitor for Treatment of ALL |
University of Colorado Denver |
Cure4Cam Childhood Cancer Foundation, I Care I Cure |
Reactivating Apoptosis in Refractory Pediatric Cancer by Molecular Inhibition of MCL-1 |
Dana-Farber Cancer Institute |
Cure4Cam Childhood Cancer Foundation |